126 related articles for article (PubMed ID: 27247490)
1. Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells.
Jia M; Wei Z; Liu P; Zhao X
J Korean Med Sci; 2016 Jun; 31(6):836-42. PubMed ID: 27247490
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
Liu H; Song X; Hou J; Zhao Z; Chang J
DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
Yin X; Liao Y; Xiong W; Zhang Y; Zhou Y; Yang Y
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1049-1057. PubMed ID: 32173903
[TBL] [Abstract][Full Text] [Related]
4. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
Cheng W; Liu T; Wan X; Gao Y; Wang H
FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2.
Awortwe C; Kaehler M; Rosenkranz B; Cascorbi I; Bruckmueller H
Xenobiotica; 2018 Oct; 48(10):1050-1058. PubMed ID: 28990842
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1
Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G
Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance.
Li WQ; Li YM; Tao BB; Lu YC; Hu GH; Liu HM; He J; Xu Y; Yu HY
Med Sci Monit; 2010 Oct; 16(10):HY27-30. PubMed ID: 20885358
[TBL] [Abstract][Full Text] [Related]
10. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
To KK; Leung WW; Ng SS
Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
[TBL] [Abstract][Full Text] [Related]
11. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
12. Drug Resistance of Endocardial Endothelial Cells is Related to Higher Endogenous ABCG2.
Ajithkumar GS; Vinitha A; Binil Raj SS; Kartha CC
Cardiovasc Toxicol; 2016 Oct; 16(4):390-405. PubMed ID: 26661076
[TBL] [Abstract][Full Text] [Related]
13. Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma.
Liu T; Wu C; Weng G; Zhao Z; He X; Fu C; Sui Z; Huang SX
Cell Physiol Biochem; 2017; 44(2):671-681. PubMed ID: 29169175
[TBL] [Abstract][Full Text] [Related]
14. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.
To KK; Robey RW; Knutsen T; Zhan Z; Ried T; Bates SE
Mol Cancer Ther; 2009 Oct; 8(10):2959-68. PubMed ID: 19825807
[TBL] [Abstract][Full Text] [Related]
15. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
16. ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin.
Chen L; Shi L; Wang W; Zhou Y
Oncotarget; 2017 Jun; 8(26):43237-43247. PubMed ID: 28591733
[TBL] [Abstract][Full Text] [Related]
17. Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase.
Wu CP; Hsieh YJ; Hsiao SH; Su CY; Li YQ; Huang YH; Huang CW; Hsieh CH; Yu JS; Wu YS
Mol Pharm; 2016 Mar; 13(3):784-94. PubMed ID: 26796063
[TBL] [Abstract][Full Text] [Related]
18. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
Anreddy N; Patel A; Zhang YK; Wang YJ; Shukla S; Kathawala RJ; Kumar P; Gupta P; Ambudkar SV; Wurpel JN; Chen ZS; Guo H
Oncotarget; 2015 Nov; 6(36):39276-91. PubMed ID: 26515463
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
Pan YZ; Morris ME; Yu AM
Mol Pharmacol; 2009 Jun; 75(6):1374-9. PubMed ID: 19270061
[TBL] [Abstract][Full Text] [Related]
20. The phytoestrogen genistein enhances multidrug resistance in breast cancer cell lines by translational regulation of ABC transporters.
Rigalli JP; Tocchetti GN; Arana MR; Villanueva SS; Catania VA; Theile D; Ruiz ML; Weiss J
Cancer Lett; 2016 Jun; 376(1):165-72. PubMed ID: 27033456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]